1. Böttcher, Jan P, Bonavita, Eduardo, Chakravarty, Probir, Zelenay, Santiago, Reis e Sousa, Caetano. 2018. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. In Cell, 172, 1022-1037.e14. doi:10.1016/j.cell.2018.01.004. https://pubmed.ncbi.nlm.nih.gov/29429633/
2. Chen, Kun, Wu, Zhiyuan, Zhao, Hong, Ma, Chunhong, Qu, Chunfeng. 2019. XCL1/Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti-PD-1 Efficacy. In Cancer immunology research, 8, 81-93. doi:10.1158/2326-6066.CIR-19-0210. https://pubmed.ncbi.nlm.nih.gov/31666238/
3. Chou, Wen-Cheng, Hsiung, Chia-Ni, Chen, Wei-Ting, Yu, Jyh-Cherng, Shen, Chen-Yang. 2020. A functional variant near XCL1 gene improves breast cancer survival via promoting cancer immunity. In International journal of cancer, 146, 2182-2193. doi:10.1002/ijc.32855. https://pubmed.ncbi.nlm.nih.gov/31904872/
4. Ewunkem, Akamu J, Deve, Maya, Harrison, Scott H, Muganda, Perpetua M. 2020. Diepoxybutane induces the expression of a novel p53-target gene XCL1 that mediates apoptosis in exposed human lymphoblasts. In Journal of biochemical and molecular toxicology, 34, e22446. doi:10.1002/jbt.22446. https://pubmed.ncbi.nlm.nih.gov/31953984/
5. Lei, Yu, Takahama, Yousuke. 2011. XCL1 and XCR1 in the immune system. In Microbes and infection, 14, 262-7. doi:10.1016/j.micinf.2011.10.003. https://pubmed.ncbi.nlm.nih.gov/22100876/
6. Bergamaschi, Cristina, Pandit, Hrishikesh, Nagy, Bethany A, Felber, Barbara K, Pavlakis, George N. . Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. In Journal for immunotherapy of cancer, 8, . doi:10.1136/jitc-2020-000599. https://pubmed.ncbi.nlm.nih.gov/32461349/
智鼠故事 
